<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Alcohol Clin Exp Res (Hoboken)</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Alcohol (Hanover, York County, Pa.)</journal-title></journal-title-group><issn pub-type="epub">2993-7175</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10197957</article-id><article-id pub-id-type="pmcid-ver">PMC10197957.1</article-id><article-id pub-id-type="pmcaid">10197957</article-id><article-id pub-id-type="pmcaiid">10197957</article-id><article-id pub-id-type="manuscript-id">NIHMS1861608</article-id><article-id pub-id-type="pmid">36543333</article-id><article-id pub-id-type="doi">10.1111/acer.15004</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1861608</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1861608</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Alcohol withdrawal produces changes in excitability, population discharge probability, and seizure threshold</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Alberto</surname><given-names initials="GE">Gregory E.</given-names></name><degrees>MD, PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Klorig</surname><given-names initials="DC">David C.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Goldstein</surname><given-names initials="AT">Allison T.</given-names></name><degrees>MS</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Godwin</surname><given-names initials="DW">Dwayne W.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A4" ref-type="aff">4</xref><xref rid="A5" ref-type="aff">5</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>1.</label>Wake Forest School of Medicine; Department of Neurobiology and Anatomy; Winston-Salem, NC, USA</aff><aff id="A2"><label>2.</label>Wake Forest School of Medicine; Department of Neurology; Winston-Salem, NC, USA</aff><aff id="A3"><label>3.</label>Dartmouth-Hitchcock Medical Center; Department of Psychiatry; Lebanon, NH, USA</aff><aff id="A4"><label>4.</label>Research and Education Department, W.G. (Bill) Hefner Veterans Affairs Medical Center; Salisbury, NC, USA</aff><aff id="A5"><label>5.</label>Wake Forest School of Medicine; Department of Physiology and Pharmacology; Winston-Salem, NC, USA</aff><author-notes><corresp id="CR1"><label>*</label>Corresponding Author: 1 Medical Center Blvd, Winston-Salem, NC 27157; (336) 716-9231; <email>dgodwin@wakehealth.edu</email></corresp><fn fn-type="COI-statement" id="FN1"><p id="P29">The authors declare no competing financial or other conflicts of interest.</p></fn></author-notes><pub-date pub-type="ppub"><month>2</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>04</day><month>1</month><year>2023</year></pub-date><volume>47</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">436151</issue-id><fpage>211</fpage><lpage>218</lpage><pub-history><event event-type="nihms-submitted"><date><day>13</day><month>05</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>02</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>02</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 11:25:31.053"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1861608.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">Alcohol withdrawal syndrome (AWS) results from sudden cessation of chronic alcohol use and is associated with high morbidity and mortality. Alcohol withdrawal-induced central nervous system (CNS) hyper-excitability results from complex, compensatory changes in synaptic efficacy and intrinsic excitability. These changes in excitability counteract the depressing effects of chronic ethanol on neural transmission and underlie symptoms of AWS from mild anxiety to seizures and death. Development of targeted pharmacotherapies for treating AWS has been slow, due in part to the lack of available animal models that capture the key features of human AWS. Using a unique optogenetic method of probing network excitability, we demonstrate electrophysiological correlates of hyper-excitability sensitive to early changes in CNS excitability. This method is sensitive to pharmacological treatments that reduce excitability and may represent a platform for AWS drug development.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We have applied a newly developed method, the optogenetic population discharge threshold (oPDT), which uses light-intensity response curves to measure network excitability in chronically implanted mice. Excitability was tracked using the oPDT before, during, and after the chronic intermittent exposure (CIE) model of alcohol withdrawal (WD).</p></sec><sec id="S3"><title>Results:</title><p id="P3">Alcohol WD produced a dose-dependent leftward shift in the oPDT curve (denoting increased excitability), which was detectable in as few as 3 exposure cycles. This shift in excitability mirrored an increase in the number of spontaneous interictal spikes (IS) during withdrawal. In addition, WD lowered seizure thresholds and increased seizure severity in optogenetically-kindled mice.</p></sec><sec id="S4"><title>Conclusion:</title><p id="P4">We demonstrate that the oPDT provides a sensitive measure of alcohol withdrawal-induced hyper-excitability. The ability to actively probe the progression of excitability without eliciting potentially confounding seizures promises to be a useful tool in the preclinical development of next generation pharmacotherapies for AWS.</p></sec></abstract><kwd-group><kwd>Alcohol Withdrawal Syndrome</kwd><kwd>Seizure</kwd><kwd>Electrophysiology</kwd><kwd>Optogenetics</kwd><kwd>Interictal Spikes</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>